Steatohepatitis Global Clinical Trials Review, H1, 2015

1. RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Steatohepatitis Global Clinical Trials Review, H1, 2015 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST

2. ReportOverview Summary GlobalData's clinical trial report, “Steatohepatitis Global Clinical Trials Review, H1, 2015" provides data on the Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

3. ReportOverview • Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe

4. Tables of Contents Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Steatohepatitis 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Steatohepatitis to Gastrointestinal Clinical Trials 15

5. Similar Market Reports • Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015 • http://www.researchbeam.com/systemic-sclerosis-scleroderma-pipeline-review-h1-2015-market • Puget Sound Blood Center - Strategic SWOT Analysis Review • http://www.researchbeam.com/puget-sound-blood-center-strategic-swot-analysis-review-market • Cerner Corporation (CERN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile • http://www.researchbeam.com/cerner-corporation-cern-pharmaceuticals-and-healthcare-deals-and-alliances-profile-market

6. Contact Visit us at : http://www.researchbeam.com/steatohepatitis-global-clinical-trials-review-h1-2015-market • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States